(Q46047040)

19 December 2017

title

Association between the CYP2D6*4 polymorphism and depression or anxiety in the elderly (English)

1 reference

19 December 2017

author

Henning Tiemeier

9

1 reference

19 December 2017

Albert Hofman

6

object named as

Albert Hofman

1 reference

19 December 2017

Teun van Gelder

8

object named as

Teun van Gelder

1 reference

19 December 2017

author name string

Monique J Bijl

1

1 reference

19 December 2017

Hendrika J Luijendijk

2

1 reference

19 December 2017

Julia F van den Berg

3

1 reference

19 December 2017

Loes E Visser

4

1 reference

19 December 2017

Ron H N van Schaik

5

1 reference

19 December 2017

Arnold G Vulto

7

1 reference

19 December 2017

Bruno H Ch Stricker

10

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

published in

Pharmacogenomics

1 reference

19 December 2017

volume

10

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

541-547

1 reference

19 December 2017

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

cites work

1 reference

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

21 January 2018

1 reference

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype

21 January 2018

1 reference

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine

21 January 2018

1 reference

Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain

21 January 2018

1 reference

Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds

21 January 2018

1 reference

Association between cytochrome P450 2D6 genotype and harm avoidance

21 January 2018

1 reference

Relationship between Type A and B personality and debrisoquine hydroxylation capacity

21 January 2018

1 reference

Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?

21 January 2018

1 reference

Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6.

21 January 2018

1 reference

Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets

21 January 2018

1 reference

Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.

21 January 2018

1 reference

CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study

21 January 2018

1 reference

Determinants of disease and disability in the elderly: The Rotterdam elderly study

21 January 2018

1 reference

The Rotterdam Study: objectives and design update

21 January 2018

1 reference

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

Incidence and recurrence of late-life depression.

21 January 2018

1 reference

Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI).

21 January 2018

1 reference

Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants

21 January 2018

1 reference

Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.

21 January 2018

1 reference

Dopamine formation from tyramine by CYP2D6.

21 January 2018

1 reference

Relationship between personality and debrisoquine hydroxylation capacity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.09.9

1 reference

19 December 2017

PubMed ID

19374513

1 reference

19 December 2017